Product Program year 2020 Source: CMS Open Payments

Olympus Respiratory Accessories

Device GI & Respiratory Products

Open in the dashboard

General payments

$1,054,958

2,146 payments

Research payments

$0

0 payments

Through program year 2020, $1,054,958 in general payments and $0 in research payments were reported against Olympus Respiratory Accessories (GI & Respiratory Products).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $154,232 396
2019 General $900,726 1,750

Breakdown

Who paid General payments · program years 2019–2020
  1. Olympus Corporation of the Americas $985,215 1,965 payments
  2. Olympus America Inc. $41,360 134 payments
  3. Spiration, Inc. $26,193 45 payments
  4. Gyrus ACMI, Inc. $2,190 2 payments
Top recipients General payments · program year 2020
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $69,001 45% · 1 payment
  2. Momen Wahidi Pulmonary Disease · Chicago, IL $21,664 14% · 53 payments
  3. Alexander Chen Pulmonary Disease · Saint Louis, MO $14,180 9% · 28 payments
  4. Michael MacHuzak Pulmonary Disease · Cleveland, OH $10,540 7% · 16 payments
  5. Robert Kruklitis Critical Care Medicine · Allentown, PA $5,807 4% · 13 payments

The top 5 of 86 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pulmonary Disease Internal Medicine $70,551 83% · 60 practitioners
  2. Critical Care Medicine Internal Medicine $8,310 10% · 8 practitioners
  3. Diagnostic Radiology Radiology $2,598 3% · 2 practitioners
  4. Internal Medicine $1,864 2% · 6 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,855 2% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Texas $70,095 45% · 8 recipients
  2. North Carolina $22,809 15% · 3 recipients
  3. Missouri $15,413 10% · 3 recipients
  4. Pennsylvania $11,475 7% · 4 recipients
  5. Ohio $11,170 7% · 4 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

2,146 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record